Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and represents a significant global health concern. Infectious agents can be easily spread through respiratory droplets, and TB patients face a significant risk of mortality. The traditional sputum-based TB

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the

Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes. This study marks the first global eco

HTAsiaLink 20188-11 May 2018, Chiang Mai, ThailandMore than 200 participants from over 30  HTA organizations and other academic and policy making agencies across the global joined this conference!The themes of this years’ conference is Testing Treatments: Strengthening HTA for better healthcare.For

On 13 Oct, 2021, our outstanding presenters received big achievements by winning amazing awards at the 9th HTAsiaLink Annual Virtual Conference 2021 which virtually held on 11 – 13  October 2021. The winners are as listed below:Best Oral Presentation HSS 1st WINNER: Chanida EkakkararungrojBest Poste

On 2 Dec 2022, our outstanding presenters received big achievements by winning amazing awards at the 10th HTAsiaLink Annual Conference 2022 which virtually held on 30 November – 2 December 2022. The winners are as listed below:Best Oral PresentationsTrack: Economic EvaluationSecond Prize: Chittawan

The HTAsiaLink Annual Conference for this year happened on 4 – 7 September, hosted by the Malaysia Health Technology Assessment Section (MaHTAS) under the Ministry of Health, Malaysia. Researchers from HITAP participated in the conference and presented their research projects thr

As part of a series of events coinciding with the launch of the Gates Reference Case, Tommy Wilkinson (Adviser for Health Economics, NICE International) will be speaking on Tuesday 17 June 2014 at a lunch seminar hosted by the Center for Global Development, Washington DC. If you missed our launch ev

One day, I was perusing the news and I came across an article about the inclusion of five new high-cost drugs in the Thai benefits package. Unbeknownst to me, the Thai Universal Health Coverage (UHC) released a news article in all domestic newspapers informing the public that the Director-General of

https://www.youtube.com/watch?v=QnmnyZ14A4wIn health systems, although there are many stakeholders with different interests (healthcare practitioners, policymakers, industry, patients and the public), many share the value of better health for all. However, when a decision needs to be made, it is not